Clinical Trial Update: Treprostinil Sodium Inhalation for Patients At High Risk for ARDS [Phase 2]

View source ↗

Summary

Phase 2 trial update for treprostinil sodium inhalation in adults at high risk for ARDS; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Adult

Drugs mentioned

• treprostinil sodium inhalation (treprostinil sodium inhalation)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: TERMINATED | Results posted: 2019-10-01